c-Fos dimerization with c-Jun represses c-Jun enhancement of androgen receptor transactivation

被引:0
|
作者
Karl Tillman
Jennifer L. Oberfield
Xi-Qiang Shen
Athanasios Bubulya
Lirim Shemshedini
机构
[1] Beth Israel Deaconess Medical Center,Department of Research
[2] Glaxo Wellcome Research and Development,Department of Molecular Endocrinology
[3] University of Toledo,Department of Biology
来源
Endocrine | 1998年 / 9卷
关键词
c-Fos; c-Jun; androgen receptor; transactivation;
D O I
暂无
中图分类号
学科分类号
摘要
The transcriptional activity of the human androgen receptor (hAR), like other nuclear receptors, is dependent on accessory factors. One such factor is c-Jun, which has been shown to have a selective function of mediating androgen receptor-dependent transactivation. This c-Jun activity is inhibited by c-Fos, another protooncoprotein that can dimerize with c-Jun to form the transcription factor AP-1. Here we show that c-Jun mediates hAR-induced transactivation from the promoter of the androgen-regulated gene, human kallikrein-2 (hKLK2), and c-Fos blocks this activity. Using c-Fos truncation mutants and measuring hKLK2-dependent transcription, we have determined that the bZIP region of c-Fos is required and sufficient for inhibiting c-Jun enhancement of hAR transactivation. Further truncation analysis of the bZIP shows that the c-Fos dimerization function, mediated through the leucine zipper, is essential for the negative activity, whereas DNA binding, mediated through the basic region, is dispensable. These results suggest that heterodimerization by c-Fos with c-Jun blocks c-Jun’s ability to enhance hAR-induced transactivation.
引用
收藏
页码:193 / 200
页数:7
相关论文
共 50 条
  • [1] c-Fos dimerization with c-Jun represses c-Jun enhancement of androgen receptor transactivation
    Tillman, K
    Oberfield, JL
    Shen, XQ
    Bubulya, A
    Shemshedini, L
    ENDOCRINE, 1998, 9 (02) : 193 - 200
  • [2] c-fos、c-jun与癫痫
    陈功
    江澄川
    中华神经医学杂志, 2005, (08) : 853 - 854
  • [3] Identification of domains of c-Jun mediating androgen receptor transactivation
    Wise, SC
    Burmeister, LA
    Zhou, XF
    Bubulya, A
    Oberfield, JL
    Birrer, MJ
    Shemshedini, L
    ONCOGENE, 1998, 16 (15) : 2001 - 2009
  • [4] Identification of domains of c-Jun mediating androgen receptor transactivation
    Scott C Wise
    Lori A Burmeister
    Xiao-feng Zhou
    Athanasios Bubulya
    Jennifer L Oberfield
    Michael J Birrer
    Lirim Shemshedini
    Oncogene, 1998, 16 : 2001 - 2009
  • [5] c-Jun interacts with phospholipids and c-Fos at the interface
    Del Boca, M
    Caputto, BL
    Maggio, B
    Borioli, GA
    JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2005, 287 (01) : 80 - 84
  • [6] C-JUN AND C-FOS ARE EXPRESSED BY HUMAN MEGAKARYOCYTES
    MOUTHON, MA
    NAVARRO, S
    KATZ, A
    BRETONGORIUS, J
    VAINCHENKER, W
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (07) : 909 - 915
  • [7] Complex mechanisms for c-fos and c-jun degradation
    JarielEncontre, I
    Salvat, C
    Steff, AM
    Pariat, M
    Acquaviva, C
    Furstoss, O
    Piechaczyk, M
    MOLECULAR BIOLOGY REPORTS, 1997, 24 (1-2) : 51 - 56
  • [8] Complex mechanisms for c-fos and c-jun degradation
    Isabelle Jariel-Encontre
    Catherine Salvat
    Ann-Muriel Steff
    Magali Pariat
    Claire Acquaviva
    Olivia Furstoss
    Marc Piechaczyk
    Molecular Biology Reports, 1997, 24 : 51 - 56
  • [9] c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation
    S-Y Chen
    C Cai
    C J Fisher
    Z Zheng
    J Omwancha
    C-L Hsieh
    L Shemshedini
    Oncogene, 2006, 25 : 7212 - 7223
  • [10] c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation
    Chen, S-Y
    Cai, C.
    Fisher, C. J.
    Zheng, Z.
    Omwancha, J.
    Hsieh, C-L
    Shemshedini, L.
    ONCOGENE, 2006, 25 (54) : 7212 - 7223